Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
29/05/2026 09:21
BRIEF-Xintela Study Finds XSTEM Treatment Safe, Well Tolerated May 29 (Reuters) - Xintela AB XINT.ST:
ONE DOSE OF XSTEM FOUND SAFE AND WELL TOLERATED IN PHASE I/IIA STUDY
Source text: ID:nMFN1xCN2s
Further company coverage: XINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))